Mark Chen· @markchen90 · X·· 2 小时前AI 评分54
AI 导读
OpenAI 宣布收购 Orchestra Bio，一个帮助生物医药团队协调药物开发复杂流程的平台。OpenAI 首席研究官 Mark Chen 欢迎 Orchestra Bio 团队和 @ashokaraj_ 加入。双方将基于 Rosalind 生命科学研究模型和工具整合运营，帮助新疗法更快抵达患者。
正文 · 原文
Excited to welcome Orchestra Bio and @ashokaraj_ to OpenAI as we broaden our work in AI-assisted drug discovery!
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! https://openai.com/index/openai-to-acquire-orchestra-bio/在 X 查看被引用的帖子
来源：Mark Chen · x.com